These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 24861494)
1. Preexisting dual antiplatelet treatment increases the risk of post-thrombolysis intracranial hemorrhage in Chinese stroke patients. Pan Y; Chen Q; Liao X; Zhao X; Wang C; Liu G; Liu L; Wang C; Wang D; Wang Y; Wang Y; Neurol Res; 2015 Jan; 37(1):64-8. PubMed ID: 24861494 [TBL] [Abstract][Full Text] [Related]
2. Safety of intravenous thrombolysis for acute ischemic stroke in patients receiving antiplatelet therapy at stroke onset. Diedler J; Ahmed N; Sykora M; Uyttenboogaart M; Overgaard K; Luijckx GJ; Soinne L; Ford GA; Lees KR; Wahlgren N; Ringleb P Stroke; 2010 Feb; 41(2):288-94. PubMed ID: 20056933 [TBL] [Abstract][Full Text] [Related]
3. Symptomatic intracerebral hemorrhage after intravenous thrombolysis in Chinese patients: comparison of prediction models. Li M; Wang-Qin RQ; Wang YL; Liu LB; Pan YS; Liao XL; Wang YJ; Xu AD J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1235-43. PubMed ID: 25891755 [TBL] [Abstract][Full Text] [Related]
4. Influence of antiplatelet pre-treatment on the risk of intracranial haemorrhage in acute ischaemic stroke after intravenous thrombolysis. Dorado L; Millán M; de la Ossa NP; Guerrero C; Gomis M; López-Cancio E; Ricciardi AC; Dávalos A Eur J Neurol; 2010 Feb; 17(2):301-6. PubMed ID: 19912320 [TBL] [Abstract][Full Text] [Related]
5. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions. Seet RC; Rabinstein AA Cerebrovasc Dis; 2012; 34(2):106-14. PubMed ID: 22868870 [TBL] [Abstract][Full Text] [Related]
6. Safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke. Uyttenboogaart M; Koch MW; Koopman K; Vroomen PC; De Keyser J; Luijckx GJ Arch Neurol; 2008 May; 65(5):607-11. PubMed ID: 18332238 [TBL] [Abstract][Full Text] [Related]
7. Influence of antiplatelet pre-treatment on the risk of symptomatic intracranial haemorrhage after intravenous thrombolysis. Bravo Y; Martí-Fàbregas J; Cocho D; Rodríguez-Yáñez M; Castellanos M; de la Ossa NP; Roquer J; Obach V; Maestre J; Martí-Vilalta JL Cerebrovasc Dis; 2008; 26(2):126-33. PubMed ID: 18560215 [TBL] [Abstract][Full Text] [Related]
8. Renal Dysfunction Associated with Symptomatic Intracranial Hemorrhage after Intravenous Thrombolysis. Zhu J; Shen X; Han C; Mei C; Zhou Y; Wang H; Kong Y; Jiang Y; Fang Q; Cai X J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104363. PubMed ID: 31501038 [TBL] [Abstract][Full Text] [Related]
9. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke? Hermann A; Dzialowski I; Koch R; Gahn G J Neurol Sci; 2009 Sep; 284(1-2):155-7. PubMed ID: 19473668 [TBL] [Abstract][Full Text] [Related]
10. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST. Flint AC; Gupta R; Smith WS; Kamel H; Faigeles BS; Cullen SP; Rao VA; Bath PM; Wahlgren N; Ahmed N; Donnan GA; Int J Stroke; 2014 Aug; 9(6):705-10. PubMed ID: 25042855 [TBL] [Abstract][Full Text] [Related]
11. Symptomatic Intracerebral Hemorrhage after Intravenous Thrombolysis: Predictive Factors and Validation of Prediction Models. Nisar T; Hanumanthu R; Khandelwal P J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104360. PubMed ID: 31501036 [TBL] [Abstract][Full Text] [Related]
12. Improved prediction of poor outcome after thrombolysis using conservative definitions of symptomatic hemorrhage. Gumbinger C; Gruschka P; Böttinger M; Heerlein K; Barrows R; Hacke W; Ringleb P Stroke; 2012 Jan; 43(1):240-2. PubMed ID: 21998049 [TBL] [Abstract][Full Text] [Related]
13. Does Prior Antiplatelet Treatment Increase the Risk of Hemorrhagic Transformation and Unfavorable Outcome on Day 90 after Intravenous Thrombolysis in Acute Ischemic Stroke Patients? Chen S; Lu X; Zhang W; Han Z; Yang W; Huang X; Jin X; Wang Z; Liang H; Qiu W; Cheng J; Shao B J Stroke Cerebrovasc Dis; 2016 Jun; 25(6):1366-70. PubMed ID: 26996750 [TBL] [Abstract][Full Text] [Related]
14. Predictors of symptomatic intracranial haemorrhage in off-label thrombolysis: an analysis of the Safe Implementation of Treatments in Stroke registry. Mundiyanapurath S; Hees K; Ahmed N; Wahlgren N; Uhlmann L; Kieser M; Ringleb PA; Hacke W; Nagel S Eur J Neurol; 2018 Feb; 25(2):340-e11. PubMed ID: 29105904 [TBL] [Abstract][Full Text] [Related]
16. Does preexisting antiplatelet treatment influence postthrombolysis intracranial hemorrhage in community-treated ischemic stroke patients? An observational study. Meurer WJ; Kwok H; Skolarus LE; Adelman EE; Kade AM; Kalbfleisch J; Frederiksen SM; Scott PA Acad Emerg Med; 2013 Feb; 20(2):146-54. PubMed ID: 23406073 [TBL] [Abstract][Full Text] [Related]
17. Thrombolysis risk prediction: applying the SITS-SICH and SEDAN scores in South African patients. von Klemperer A; Bateman K; Owen J; Bryer A Cardiovasc J Afr; 2014; 25(5):224-7. PubMed ID: 25629538 [TBL] [Abstract][Full Text] [Related]
19. Intravenous Thrombolysis Is Safe and Effective for the Cryptogenic Stroke in China: Data From the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS-China). Fan Y; Liao X; Pan Y; Dong K; Wang Y; Wang Y; J Stroke Cerebrovasc Dis; 2019 Jan; 28(1):220-226. PubMed ID: 30366863 [TBL] [Abstract][Full Text] [Related]